Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT00442806 Completed - Clinical trials for Myocardial Infarction

Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction

Start date: November 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to establish safety and feasibility of utilizing Adipose-Derived Stem and Regenerative Cells (ADRC's) in patients who have suffered a ST-elevation acute myocardial infarction.

NCT ID: NCT00442325 Completed - Clinical trials for Diabetes Mellitus, Type 2

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

ACTFAST 2
Start date: January 2003
Phase: Phase 4
Study type: Interventional

European physicians tend to always use the lowest dose of statins to initiate therapy even in subjects who require large reductions in cholesterol. The study evaluates if selecting the starting dose based on baseline and target LDL-C cholesterol would provide better results (ie proportion of subjects resching target)

NCT ID: NCT00439855 Completed - Clinical trials for Coronary Artery Disease

Enoxaparin Versus Unfractionated Heparin in PCI

Start date: September 2003
Phase: Phase 4
Study type: Interventional

Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI

NCT ID: NCT00438919 Completed - Clinical trials for Coronary Artery Disease

A Multi-center Post-Market Surveillance Registry

E-SELECT
Start date: May 2006
Phase: Phase 4
Study type: Interventional

This multicenter, prospective, observational registry will evaluate the safety and performance of the CYPHER SELECTâ„¢ Sirolimus-eluting Coronary Stent, and of all future generation of commercially approved Cordis Sirolimus-eluting Stents (SES), in routine clinical practice. Its objective is to measure the incidence and identify the predictors of acute, sub-acute and late stent thrombosis and Major Adverse Cardiac Events (MACE). Additional analyses will be performed in patient sub-populations, such as diabetes, in-stent restenosis (ISR), acute myocardial infarction (AMI) and multivessel coronary disease.

NCT ID: NCT00437138 Completed - Clinical trials for Coronary Heart Disease

Controlled Exposures to Air Pollution in Patients With Coronary Heart Disease

Start date: April 2006
Phase: Phase 0
Study type: Interventional

Air pollution is a major cause of cardiovascular morbidity and mortality. The components of air pollution responsible and the mechanisms through which they might mediate these harmful effects remain only partially understood. We hypothesise that these adverse effects are mediated by combustion derived air pollutants and that even a brief exposure will effect heart and blood vessel function. We assess the effect of dilute diesel exhaust inhalation at levels encountered in urban road traffic on heart and blood vessel function in patients with stable coronary heart disease.

NCT ID: NCT00433784 Completed - Clinical trials for Coronary Artery Disease

H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

Start date: September 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study was to assess whether interpatient variability in the platelet response to clopidogrel is partly due to polymorphisms of the hepatic cytochrome P450 (CYP450)3A and of the clopidogrel-P2Y12 receptor genes.

NCT ID: NCT00432120 Completed - Clinical trials for Ischemic Heart Disease

Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?

Start date: March 2006
Phase: Phase 3
Study type: Interventional

Clopidogrel pre-treatment before planned percutaneous coronary intervention was proved to reduce periprocedural complications. However, the vast majority of patients in the current interventional cardiology practice do not undergo planned PCI, but rather "ad-hoc" PCI performed immediately after coronary angiography . Whether clopidogrel should be administered as pre-treatment to all patients undergoing elective CAG with the aim to ensure therapeutic levels at the time of possible ad-hoc PCI is not known.

NCT ID: NCT00431977 Completed - Diabetes Mellitus Clinical Trials

Validation Study of Coronary CT Angiography as a Screening Tool in Asymptomatic Diabetes

Start date: November 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the prevalence and clinical predictors of subclinical coronary atherosclerosis and to validate the usefulness of coronary CT angiography as a screening tool in asymptomatic patients with type 2 diabetes mellitus.

NCT ID: NCT00431717 Completed - Diabetes Mellitus Clinical Trials

Coronary Computed Tomography Angiography and SPECT in Asymptomatic Diabetes

Start date: November 2006
Phase: N/A
Study type: Observational

The purpose of this study is to compare the difference of diagnostic efficiency between coronary CT angiography and myocardial perfusion single photon emission computerized tomography in asymptomatic patients with type 2 diabetes mellitus.

NCT ID: NCT00430989 Completed - Clinical trials for Coronary Artery Disease

The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial

Start date: April 2007
Phase: Phase 4
Study type: Interventional

To investigate the safety of nitrous oxide (N2O) anaesthesia in patients with risk factors for coronary artery disease undergoing major surgery.